Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks

Brain

Volumn 137, Issue 1, 2014, Pages 232-241

  Maniyar, Farooq Husain ^a,b,c   Sprenger, Till ^a,d   Monteith, Teshamae ^a,e   Schankin, Christoph ^a   Goadsby, Peter James ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

^c BASILDON HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

hypothalamus; migraine; periaqueductal grey; PET; premonitory

Indexed keywords

GLYCERYL TRINITRATE; WATER O 15;

ADULT; ANTERIOR CINGULATE; ARTICLE; BRAIN ACTIVATION; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN REGION; CLINICAL ARTICLE; EPISODIC MIGRAINE; FATIGUE; FEMALE; FUNCTIONAL NEUROIMAGING; HUMAN; HYPOTHALAMUS; MALE; MESENCEPHALON; MICTURITION; MIDDLE AGED; MIGRAINE; MIGRAINE WITHOUT AURA; MOOD CHANGE; MUSCLE RIGIDITY; NECK STIFFNESS; NERVE CELL; OCCIPITAL CORTEX; OUTCOME ASSESSMENT; PERIAQUEDUCTAL GRAY MATTER; PHOTOPHOBIA; PONS; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; POSTERIOR HYPOTHALAMUS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; SUBSTANTIA NIGRA; TEMPORAL CORTEX; THIRST; VENTRAL TEGMENTUM; YAWNING; YOUNG ADULT;

HYPOTHALAMUS; MIGRAINE; PERIAQUEDUCTAL GREY; PET; PREMONITORY;

ADULT; BRAIN; CEREBROVASCULAR CIRCULATION; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; FEMALE; HUMANS; HYPOTHALAMUS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MIGRAINE WITHOUT AURA; NITROGLYCERIN; PERIAQUEDUCTAL GRAY; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; VASODILATOR AGENTS; YOUNG ADULT;

EID: 84892735076     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt320     Document Type: Article

References (39)

1. Abrams J. Pharmacology of nitroglycerin and long-acting nitrates. Am J Cardiol 1985; 56: 12A-18A.
2. Afridi S, Giffin NJ, Kaube H, Friston KJ, Ward NS, Frackowiak RSJ, et al. A PET study in spontaneous migraine. Arch Neurol 2005a; 62: 1270-5.
3. Afridi S, Kaube H, Goadsby PJ. Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain 2004; 110: 675-80.
4. Afridi S, Matharu MS, Lee L, Kaube H, Friston KJ, Frackowiak RSJ, et al. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain 2005b; 128: 932-9.
5. Akerman S, Holland P, Goadsby PJ. Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci 2011; 12: 570-84.
6. Argiolas A, Melis MR. The neuropharmacology of yawning. Eur J Pharmacol 1998; 343: 1-16.
7. Bahra A, Matharu MS, Buchel C, Frackowiak RSJ, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet 2001; 357: 1016-7.
8. Bartsch T, Levy MJ, Knight YE, Goadsby PJ. Differential modulation of nociceptive dural input to [hypocretin] Orexin A and B receptor activation in the posterior hypothalamic area. Pain 2004; 109: 367-78.
9. Cao Y, Aurora SK, Nagesh V, Patel SC, Welch KM. Functional MRIBOLD of brainstem structures during visually triggered migraine. Neurology 2002; 59: 72-8.
10. Charbit AR, Akerman S, Holland PR, Goadsby PJ. Neurons of the dopaminergic/CGRP A11 cell group modulate neuronal firing in the trigeminocervical complex: an electrophysiological and immunohistochemical study. J Neurosci 2009; 29: 12532-41.
11. Christiansen I, Thomsen LL, Daugaard D, Ulrich V, Olesen J. Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia 1999; 19: 660-7.
12. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998; 95: 322-7.
13. DeArmond SJ, Fusco MM, Dewey MM. Photographic atlas-structure of the human brain. 2nd edn. New York: Oxford University Press; 1976.
14. Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G. Hypothalamic activation in spontaneous migraine attacks. Headache 2007; 47: 1418-26.
15. Ferguson AV, Samson WK. The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function. Front Neuroendocrinol 2003; 24: 141-50.
16. Frackowiak RSJ, Friston KJ. Functional neuroanatomy of the human brain: positron emission tomography-a new neuroanatomical technique. J Anat 1994; 184: 211-25.
17. Friston K. Ten ironic rules for non-statistical reviewers. Neuroimage 2012; 61: 1300-10.
18. Giffin NJ, Ruggiero L, Lipton RB, Silberstein S, Tvedskov JF, Olesen J, et al. Premonitory symptoms in migraine: an electronic diary study. Neurology 2003; 60: 935-40.
19. Headache Classification Committee of The International Headache Society. The international classification of headache disorders (second edition). Cephalalgia 2004; 24 (Suppl 1): 1-160.
20. Iversen HK, Olesen J, Tfelt-Hansen P. Intravenous nitroglycerin as an experimental headache model. Basic characteristics. Pain 1989; 38: 17-24.
21. Kelman L. The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs. Headache 2004; 44: 865-72.
22. Knight YE, Bartsch T, Kaube H, Goadsby PJ. P/Q-type calcium channel blockade in the PAG facilitates trigeminal nociception: a functional genetic link for migraine? J Neurosci 2002; 22: 1-6.
23. Krowicki ZK, Kapusta DR. Microinjection of glycine into the hypothalamic paraventricular nucleus produces diuresis, natriuresis, and inhibition of central sympathetic outflow. J Pharmacol Exp Ther 2011; 337: 247-55.
24. Lance JW, Lambert GA, Goadsby PJ, Duckworth JW. Brainstem influences on cephalic circulation: experimental data from cat and monkey of relevance to the mechanism of migraine. Headache 1983; 23: 258-65.
25. Lassen LH, Ashina M, Christiansen I, Ulrich V, Olesen J. Nitric oxide synthesis inhibition in migraine. Lancet 1997; 349: 401-2.
26. May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet 1998; 352: 275-8.
27. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197-223.
28. Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jonsson B. The economic cost of brain disorders in Europe. Eur J Neurol 2012; 19: 155-62.
29. Olesen J, Thomsen LL, Lassen LH, Olesen IJ. The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia 1995; 15: 94-100.
30. Raskin NH, Hosobuchi Y, Lamb S. Headache may arise from perturbation of brain. Headache 1987; 27: 416-20.
31. Sakurai T. Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology. Regul Pept 2005; 126: 3-10.
32. Schoenen J, Ambrosini A, Sandor PS, Maertens de Noordhout A. Evoked potentials and transcranial magnetic stimulation in migraine: published data and viewpoint on their pathophysiologic significance. Clin Neurophysiol 2003; 114: 955-72.
33. Schytz HW, Ciftci K, Akin A, Ashina M, Bolay H. Intact neurovascular coupling during executive function in migraine without aura: interictal near-infrared spectroscopy study. Cephalalgia 2010; 30: 457-66.
34. Sokolowski K, Corbin JG. Wired for behaviors: from development to function of innate limbic system circuitry. Front Mol Neurosci 2012; 5: 55.
35. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 2003; 290: 2443-54.
36. Waelkens J. Domperidone in the prevention of complete classical migraine. BMJ 1982; 284: 944.
37. Waelkens J. Dopamine blockade with domperidone: bridge between prophylactic and abortive treatment of migraine? A dose-finding study. Cephalalgia 1984; 4: 85-90.
38. Weiller C, May A, Limmroth V, Juptner M, Kaube H, Schayck RV, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995; 1: 658-60.
39. You ZB, Chen YQ, Wise RA. Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation. Neuroscience 2001; 107: 629-39.